Navigation Links
Hope International Centro de Radioterapia of Guatemala Becomes First in Latin America to Treat Cancer Using RapidArc(R) Radiotherapy Technology From Varian Medical Systems
Date:12/22/2009

GUATEMALA CITY, Dec. 22 /PRNewswire-FirstCall/ -- Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: VAR), one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme--an aggressive type of brain tumor.

Clinicians at the center, which treats patients from across Central America, carried out the first treatment for a 66-year-old attorney whose prostate cancer recurred a year after it was first treated using robotic surgery. His first RapidArc treatment was delivered in 3.16 minutes using two arcs, or rotations, of the machine around the patient. By comparison, conventional IMRT (intensity-modulated radiation therapy) treatments would have taken eight to ten minutes.

Using the image-guidance technology that is integral to the RapidArc treatment process, clinicians were able to detect a 2-3 millimeter displacement of the targeted tumor after they positioned the patient for his first treatment. "We could then make a very fine adjustment in the patient's position, to ensure that we were accurately targeting the tumor and sparing surrounding tissues to the greatest extent possible," said Luis A. Linares, MD, Medical Director.

Linares and his medical team generated conventional IMRT treatment plans as well as RapidArc plans for all four patients, in order to compare and choose the one most likely to result in the best possible outcome. "In every case, the RapidArc plans were superior, as far as quality of the dose distribution was concerned," Dr. Linares said. "We saw better coverage of the targeted tumor, and better normal tissue sparing. For the rectal cancer patient, doses to the bladder and femoral heads were significantly lower with the RapidArc plan. For the prostate cancer patient, RapidArc did a better job of protecting both the bladder and the rectum. And for the patient with recurrent glioblastoma, we saw a definite advantage to the RapidArc plan, in terms of protecting the optic nerve and optic chiasm."

RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and makes it possible to deliver advanced image-guided intensity

modulated radiotherapy (IMRT) up to eight times faster than is possible with conventional IMRT. RapidArc technology directs the treatment beam at a tumor while continuously rotating around the patient. Conventional IMRT treatments are slower because they target tumors using a complex sequence of fixed beams from multiple angles.

"Faster treatments have the potential to be even more precise, since there is less chance of the patient or tumor moving during treatment," Dr. Linares said.

"We are pleased to hear that the first RapidArc treatments have now been delivered at this important cancer treatment facility in Central America," said James Miles, Varian's director of operations for Latin American and the Caribbean. "RapidArc is enabling more and more cancer centers around the world to offer patients the most modern treatments available."

Selected studies showing improved outcomes for prostate and head and neck cancer patients treated with IMRT as compared with other forms of radiotherapy, and demonstrating the magnitude of tumor motion that can take place during a prostate cancer treatment.

About Hope International

Hope International Centro de Radioterapia in Guatemala City is a modern, warm facility located within 15 minutes of the international airport in Aurora, close to hotels and tourist services. The center's mission is to offer internal and external forms of radiotherapy in the treatment of cancer, using state-of-the-art technology. Patients receive attentive care in a friendly, pleasant atmosphere. For more information, visit http://www.hoperadioterapia.com.

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, China and Europe and in its 79 sales and support offices around the world. For more information, visit http://www.varian.com/.


    FOR INFORMATION CONTACT:
    Meryl Ginsberg, Varian Medical Systems
    650-424-6444 or meryl.ginsberg@varian.com

    Pablo Aparicio, Hope International
    (502) 2311-0400 or paparicio@hoperadiotherapy.com

SOURCE Varian Medical Systems, Inc.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia
2. Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit
3. SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System
4. Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
5. CPG International Launches a New Generation of VYCOM
6. SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology
7. National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees Choice New Product Awards
8. PRA International Hosts an Infectious Diseases Audio Conference
9. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
10. Reportlinker Adds Chiral Technology - International Technology & Market Trends
11. Swissray International Announces New Ownership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... March 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), ... inherited liver diseases in children, today reported financial ... ended December 31, 2016 and provided an update ... continued to make progress during the fourth quarter ... from our non-human primate safety study, and with our ...
(Date:3/24/2017)... Research and Markets has announced the ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 report ... cell therapy manufacturing and focuses both on contract manufacturers and ... anticipated to emerge as viable alternatives to conventional treatment options. ...
(Date:3/24/2017)... , March 24, 2017  Zymo ... company, and Hamilton Robotics, Inc., who designs, ... an ongoing collaboration that teams Zymo Research,s ... RNA and DNA extraction products with Hamilton,s ... created optimized methods for microbiomics and RNA ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... 27, 2017 , ... The Association of Healthcare and Value ... their first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes will provide the ... value analysis professionals have a ‘seat at the table’ with clinical committees when ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is consistently becoming ... require expert user knowledge. In a live webinar on April 11th and October ... highly accurate, determination of sodium. , It has long been known that too ...
(Date:3/27/2017)... Fla. (PRWEB) , ... March 27, 2017 , ... ... overdose deaths soared 167%,(1) with opioids alone responsible for over 33,000 of the ... McCarty has sponsored Assembly Bill (AB) 1512, which proposes a tax on prescription ...
(Date:3/25/2017)... ... ... Getting earned media coverage meaningful for Garden Media Group's clients is the ... Garden Media aims to provide material helpful to clients’ goals and bottom lines. By ... messages to gain coveted media placements, Garden Media wows clients year-round. , Here ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... will spark a conversation on the current obstacles facing infection prevention and offer ... preventable deaths caused by these infections. , The print component of “Fighting ...
Breaking Medicine News(10 mins):